The primary event in the process of viral entry into a target cell is the interaction between the virus and its cellular receptor and the specificity of this interaction determines both viral cell tropism and pathogenicity. For the primate lentiviruses the viral receptor is CD4, targeting the virus to helper T cells, resulting in their depletion and the eventual development of AIDS (1). However, CD4-expression alone is insufficient to confer susceptibility to infection with HIV, which also depends on expression of co-receptors, principally the chemokine receptors CXCR4 and CCR5 (2) . The virus attaches via a high affinity interaction with CD4, resulting in a conformational change in the envelope glycoprotein (Env) and exposing the binding site for the chemokine receptor (3). This then triggers a further conformational change that exposes the fusion domain of the viral transmembrane protein gp41 and enables fusion of the viral and cellular membranes (4).
The feline immunodeficiency virus (FIV) is unique among the non-primate lentiviruses in that in its natural host species, the domestic cat, it induces a disease similar to AIDS, characterised by a progressive depletion of CD4+ T lymphocytes (5).
Consequently, an immunodeficiency syndrome develops characterised by wasting, neurological manifestations, chronic stomatitis and gingivitis and an increased incidence of lymphoma (6) . However, CD4 is not the primary receptor for FIV, suggesting that the virus may bind to an alternative molecule in order to target CD4+ T cells (7) . Partial elucidation of the mechanism of infection with FIV was provided by the discovery that primary isolates and laboratory strains of virus use CXCR4 as a co-factor for infection (8, 9) . However CXCR4 expression alone was insufficient to confer susceptibility to infection with primary isolates of FIV, indicating the existence of an as yet unidentified primary receptor for the virus.
To identify the primary receptor for FIV, we generated a cDNA library in the pMX retroviral vector from an IL2-dependent CD4+ feline T cell line (MYA-1), which is highly susceptible to infection with FIV (10) . Following transduction of P3U1 murine myeloma cells with the library, cells capable of binding FIV were identified by "panning" with FIV-coated plates (11) . Positive colonies were expanded and genomic DNA prepared and the cDNA insert amplified from the retroviral vector by PCR. Of three cDNAs cloned from the library, only one showed reproducible binding to FIV when re-expressed in P3U1 cells and was characterised as the feline homologue of CD134 (DDBJ accession no. AB128982). CD134 was first described as MRC OX-40, an antigen expressed on activated rat CD4+ T lymphocytes and a novel member of the TNF-NGF receptor family (12, 13) . The feline CD134 cDNA identified here predicts a 270 amino acid protein with strong identity to human CD134 (Fig. 1A ).
To confirm that the feline CD134 protein binds FIV, we expressed the cDNA in the human cell line Plat-E and the murine cell line NIH-3T3. Specific FIV binding was detected on Plat-E and NIH 3T3 cells transduced with CD134 but not with cells expressing CD2 from the same vector (Fig. 1B. ).
To assess whether CD134 acts as a functional viral receptor, the feline large granular lymphoma cell line MCC (these cells are refractory to infection with primary strains of FIV) was stably transduced with a retroviral vector bearing the CD134 cDNA. Surface CD134 expression was detected by flow cytometry ( Fig. 2A ) while a ~45kDa species was detected by immunoblotting ( (Fig. 2D.) , confirming that CD134 expression overcame the block to viral entry into these cells. CD134-expression also relieved the block to infection in the feline fibroblast line AH927 while a control vector encoding the FeLV-C receptor (FeLVC-R) had no effect (Fig.S1 ).
Syncytium formation occurs when Env expressed on the surface of a cell comes into contact with an adjacent cell expressing the viral receptor and co-receptor 3E-G) led to the development of syncytia whereas no syncytia were observed in the control cultures (Fig. 3A-C) expressing the FeLV-CR. In contrast, FIV-PET env (derived from a FIV strain analogous to CD4-independent strains of HIV (14)) induced syncytium formation in both the CD134 (Fig. 3H) and FeLV-CR-expressing (Fig. 3D ) cells, consistent with this Env interacting with CXCR4 in the absence of a primary receptor (15) .
Human cells are refractory to infection with primary strains of FIV (16) . We therefore examined species-specificity of the interaction between FIV and CD134. The human cell line HeLa was stably transduced with either feline or human CD134 and surface expression of CD134 was confirmed by flow cytometry (Fig. 4B) . Although ectopic expression of feline CD134 rendered HeLa cells permissive for infection with primary FIV strain GL8 or TM2 pseudotypes (Fig. 4A ) human CD134 expression had little effect. In contrast, the susceptibility of the feline and human CD134-expressing cells to HIV pseudotypes with VSV-G envelope was broadly similar to the control HeLa cells. Similarly, feline, but not human, CD134 expression permitted infection with HIV pseudotypes bearing FIV envelopes and encoding GFP (Fig. 4B) . These results suggest that the specificity of the interaction between the virus and its primary receptor may be a major determinant of the species specificity of FIV.
Since infection with both primary and cell culture adapted strains of FIV is CXCR4-dependent (8,9), we determined whether CD134-dependent infection required co-expression of CXCR4. HeLa cells express high levels of CXCR4 and human CXCR4 is an efficient co-receptor for FIV (17) . Infection of HeLa-CD134 cells with GL8 and TM2 pseudotypes was inhibited efficiently by the selective CXCR4 antagonist AMD3100 while infection with control HIV (VSV) pseudotypes was not affected (Fig. 4C) , confirming an absolute requirement for both receptor and coreceptor.
Further evidence for a role for CD134 in viral infection was provided by downregulation of CD134 from the surface of FIV infected cells (Fig. S2) . Moreover, CD134-expressing cells expressed similar levels of CXCR4 to control cells, indicating that CD134 did not mediate its effect on FIV infection by modulating CXCR4 expression (Fig. S3) .
We have shown that CD134 functions as a novel primary receptor for an immunodeficiency-causing lentivirus. CD134 expression is largely restricted to CD4+ T lymphocytes (12, (18) (19) (20) , however, in humans and mice CD134 is also expressed at lower levels on activated CD8+ T cells (18, 21) , macrophages and activated B cells 
